Summary

for people ages 1-17 (full criteria)
at UC Davis
study started
estimated completion
Stephanie Crossen, MD, MPH(ucdavis)

Description

Summary

At the conclusion of this project, investigators will have assessed the effectiveness of home-based telemedicine for improving multiple important clinical and patient-centered outcomes in a high-risk pediatric cohort with T1D. Aim 1. To test the hypothesis that home-based telemedicine is a feasible and acceptable method of care delivery for patients with poorly controlled type 1 diabetes (T1D) currently cared for at the University of California, Davis (UCD) Pediatric Endocrinology clinic. Specifically: A) Patients and families choose to participate in telemedicine visits as a supplement to in-person care; B) Patients and families can utilize secure, internet-based platforms to upload and share glucose meter data and to establish an audio-video connection with a diabetes specialist in their home settings; C) Patients and families are satisfied with the experience of home-based telemedicine and would choose to receive future diabetes care via this modality. Aim 2. To test the hypothesis that using home-based telemedicine, these patients can complete more frequent visits with a diabetes specialist than they previously completed via office visits alone. Aim 3. To test the hypothesis that increased contact with a diabetes specialist via home-based telemedicine will lead to significant improvement in glycemic control for these patients. Aim 4. To evaluate the effects of increased contact with a diabetes specialist via home-based telemedicine on high-cost health care utilization - specifically emergency department (ED) visits and diabetes-related hospitalizations.

Official Title

Use of Home-Based Telemedicine to Improve Healthcare Utilization and Outcomes in Pediatric Patients With Poorly Controlled Type 1 Diabetes

Keywords

Diabetes Mellitus, Type 1 Pediatrics Diabetes Mellitus Telemedicine Intervention

Eligibility

You can join if…

Open to people ages 1-17

  • age 1-17 years
  • known diagnosis of T1D
  • >1 prior visit to the UC Davis Pediatric Endocrinology clinic (to avoid enrolling newly diagnosed patients)
  • suboptimal glycemic control, defined as most recent hemoglobin A1C level of >8%
  • access to the internet via a device with video and audio capability (e.g. computer, tablet, mobile phone)
  • ability to connect their home glucose meter to an internet-capable device via Bluetooth or physical cable for the purpose of data uploading.

You CAN'T join if...

  • Patients and parents whose primary language is not English
  • Patients who have Western Health Advantage health insurance

Location

  • University of California-Davis
    Sacramento California 95817 United States

Lead Scientist

  • Stephanie Crossen, MD, MPH (ucdavis)
    Assistant Professor, General Pediatrics. Authored (or co-authored) 13 research publications

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
ID
NCT03374462
Study Type
Interventional
Last Updated